Lessee, Operating Lease, Liability, to be Paid of Actinium Pharmaceuticals, Inc. from 30 Sep 2023 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: Actinium Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Sep 2023 to 31 Mar 2025.
Actinium Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Mar 2025 was $1,498,000, a 29% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Actinium Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$1,498,000	-$621,000	-29%	31 Mar 2025	10-Q	09 May 2025	2025	Q1
Q4 2024	$1,653,000			31 Dec 2024	10-K	31 Mar 2025	2024	FY
Q1 2024	$2,119,000			31 Mar 2024	10-Q	26 Apr 2024	2024	Q1
Q3 2023	$2,271,000			30 Sep 2023	10-K	29 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.